Overview

𝗚𝗿𝗼𝘂𝗻𝗱𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝗳𝗼𝗿 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿'𝘀, 𝗣𝗮𝗿𝗸𝗶𝗻𝘀𝗼𝗻'𝘀, 𝗮𝗻𝗱 𝗟𝗲𝘄𝘆 𝗕𝗼𝗱𝘆 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮. 𝗪𝗲 detect 𝘁𝗵𝗲 misfolded proteins 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝘁𝗵𝗲𝘀𝗲 𝗯𝗿𝗮𝗶𝗻 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀. Amprion pioneers Testing for diseases associated with mis-folded proteins. Detection Testing℠ for Alzheimer’s and Parkinson’s. For the first time in history, our proprietary molecular-based diagnostic technology tracks ththat drive Alzheimer’s and Parkinson’s prior to any clinical. Early diagnosis of Alzheimer’s and Parkinson’s empowers us to find a cure to stop these diseases on their tracks. Alzheimer’s and Parkinson’s are two related diseases on a spectrum: https://www.ampriondx.com == About FDA Breakthrough Device Designation === FDA’s Breakthrough Devices Program is designed to speed up development, assessment and review of medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. == How Amprion Works === Amprion’s breakthrough early testing for Alzheimer's and Parkinson's detects mis-folded proteins or, biomarkers, using spinal fluid (CSF).